Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib plus Gemcitabine vs Gemcitabine in Metastatic Pancreatic Cancer
NCT01728818Phase 2Unknown
- Sponsor
- Volker Heinemann
- Start
- Apr 2013
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afatinib, sponsored by Volker Heinemann. Status: unknown.
02
Drugs
afatinib
Beyond the preview
Go deeper on NCT01728818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01728818.